Agilent at ECP 2023

Neil Ryan
VP Laboratory Operations at Cyted, UK.

Abstract:
The use of capsule sponge testing as a minimally invasive, non-endoscopic approach for early cancer detection.  A summary of real world data showing impacts across the UK and the role played by digital pathology.

Biography:
Neil Ryan currently performs the role of VP Laboratory Operations, and is responsible for leading all the laboratory operations and outputs at Cyted.  Cyted is a data-driven diagnostics company that seeks to help in the earlier and faster diagnosis of cancer. Using a novel cell sampling methodology, Cyted drives earlier detection to protect oesophageal health by monitoring for signs of pre-cancer and other disease.  Cyted's laboratory uses digital technology for 100% of its diagnostic reporting.  Neil has over 20 years experience working within cellular and molecular pathology across sectors. He has performed a range of senior leadership and Board level roles, most recently within private healthcare diagnostics businesses. Alongside his role at Cyted, Neil also operates as a Non-Exec Director for UKNEQAS CPT.

James Blackwood,
NHS Greater Glasgow and Clyde, UK.

Abstract:
NHS GGC began its journey to digitise pathology operations in 2017. During his talk, James Blackwood will share lessons learned and cover requirements for an interoperable platform that serves as the center of gravity for the digital pathology ecosystem to power primary diagnostic workflows and incorporate a broad portfolio of AI applications. He’ll also speak to why a singular platform that drives diagnostic and research workflows is enabling his team to tap into the full potential of its data

Biography:
James Blackwood is currently the AI Strategy and Portfolio Lead for NHS Greater Glasgow and Clyde.  
He previously held the role of CTO & NHS National Programme Manager for iCAIRD, one of the UK’s largest healthcare AI research programmes, based in Scotland, with over 50 projects across radiology and pathology AI.  iCAIRD digitised the pathology lab at NHS Greater Glasgow and Clyde, which with around 70 pathologists, generates over 500,000 digital whole slide histopathology images each year and has accumulated over 2PB of WSI data so far.  JD was also the Healthcare AI Lead in Scottish Government.
James Blackwood is a generalist with a background in product and service innovation; digital customer experience design; cutting-edge technology architecture including artificial intelligence; large-scale international programme delivery; and starting, scaling and running technology companies.  He is passionate about using technology to improve lives.

Dr. Shawn Kinsey
Gastrointestinal Pathologist and the Laboratory Director for PathAI Diagnostics, USA. 

Abstract:
Dr. Shawn Kinsey will provide an overview of various metrics and user feedback collected from our Early Access Program partners. The scope of offerings included is our AISight IMS as well as AIM-PDL1-NSCLC and AIM-HER2-Breast AI algorithms and the scope of data to be discussed includes workflow efficiency metrics and concordance and discordance analyses.

Biography:
Dr. Shawn Kinsey completed his anatomic and clinical pathology residency at UT Southwestern in Dallas, Texas; staying an additional year as a gastrointestinal/hepatic pathology fellow. In 2012, Dr. Kinsey relocated to Memphis, Tennessee to join Poplar Healthcare, a multidisciplinary national reference laboratory, becoming the laboratory director in 2015. He oversaw the implementation of digital pathology in the practice starting in 2020. Following PathAI's acquisition of the practice, Dr. Kinsey has been involved in algorithm development, validation, and implementation at PathAI Diagnostics; which has grown to be one of the largest independent anatomic pathology laboratories in the United States.

Professor Paul J van Diest,
MD PhD. Head of Pathology Department at University Medical Center, Utrecht, The Netherlands.